Compositions and methods for inhibiting expression of Eg5 and VEGF genes

• 收藏
• 分享

专利权人:

Alnylam Pharmaceuticals; Inc.

发明人:

Bumcrot, David,Sah Dinah, Wen-Yee,Toudjarska, Ivanka

申请号：

AU2009221775

公开号：

AU2009221775B2

申请日:

2009.03.05

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

This invention relates to compositions containing double-stranded ribonucleic acid (dsRNA) in a SNALP formulation, and methods of using the compositions to inhibit the expression of the Eg5 and Vascular Endothelial Growth Factor (VEGF), and methods of using the compositions to treat pathological processes mediated by Eg5 and VEGF expression, such as cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/